Vaccines
Study data from University of North Carolina update knowledge of vaccines
Published in Vaccine Weekly, January 30th, 2008
Researchers detail in 'Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine,' new data in vaccines. "Genetic vaccines are engineered to produce immunogens de novo in the cells of the host for stimulation of a protective immune response. In some of these systems, antigens engineered for rapid degradation have produced an enhanced cellular immune response by more efficient entry into pathways for processing and presentation of MHC class I peptides," investigators in the United States report.
"VEE replicon particles (VRP), single cycle vaccine vectors derived from Venezuelan equine encephalitis virus...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-01-30)
More Articles from Vaccine Weekly
- HIV/AIDS
Keeping young South Africans in school: A 'social vaccine' against AIDS - HIV/AIDS
Uncovering the Achilles' heel of the HIV-1 envelope - HIV/AIDS
Study findings from Emory University, Emory Vaccine Center provide new insights into HIV/AIDS - Human Papillomavirus
New findings from Korea University describe advances in human papillomavirus - Immunization
Reports by V.E.J.C. Schijns and co-researchers describe recent advances in immunization - The Children's Hospital of Philadelphia
Medicaid Reimbursement for Car Seats Is Cost-Effective Health Policy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
